Charles Schwab’s Adicet Bio ACET Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $18.3K | Hold |
30,000
| – | – | ﹤0.01% | 3489 |
|
|
2025
Q1 | $22.7K | Hold |
30,000
| – | – | ﹤0.01% | 3458 |
|
|
2024
Q4 | $28.9K | Sell |
30,000
-40
| -0.1% | -$38 | ﹤0.01% | 3474 |
|
|
2024
Q3 | $43.3K | Sell |
30,040
-126
| -0.4% | -$181 | ﹤0.01% | 3427 |
|
|
2024
Q2 | $36.5K | Sell |
30,166
-119,910
| -80% | -$145K | ﹤0.01% | 3551 |
|
|
2024
Q1 | $353K | Buy |
150,076
+80,616
| +116% | +$189K | ﹤0.01% | 3138 |
|
|
2023
Q4 | $131K | Hold |
69,460
| – | – | ﹤0.01% | 3324 |
|
|
2023
Q3 | $95.2K | Sell |
69,460
-13,243
| -16% | -$18.1K | ﹤0.01% | 3358 |
|
|
2023
Q2 | $201K | Buy |
82,703
+1,533
| +2% | +$3.73K | ﹤0.01% | 3307 |
|
|
2023
Q1 | $468K | Hold |
81,170
| – | – | ﹤0.01% | 2971 |
|
|
2022
Q4 | $726K | Buy |
81,170
+5,854
| +8% | +$52.3K | ﹤0.01% | 2888 |
|
|
2022
Q3 | $1.07M | Buy |
75,316
+3,821
| +5% | +$54.3K | ﹤0.01% | 2770 |
|
|
2022
Q2 | $1.04M | Buy |
71,495
+4,692
| +7% | +$68.5K | ﹤0.01% | 2774 |
|
|
2022
Q1 | $1.34M | Buy |
66,803
+15,116
| +29% | +$302K | ﹤0.01% | 2764 |
|
|
2021
Q4 | $905K | Buy |
51,687
+2,127
| +4% | +$37.2K | ﹤0.01% | 2953 |
|
|
2021
Q3 | $389K | Hold |
49,560
| – | – | ﹤0.01% | 3210 |
|
|
2021
Q2 | $510K | Buy |
+49,560
| New | +$510K | ﹤0.01% | 3163 |
|
|
2020
Q3 | – | Sell |
-8,973
| Closed | -$136K | – | 3344 |
|
|
2020
Q2 | $136K | Sell |
8,973
-3,463
| -28% | -$52.5K | ﹤0.01% | 3217 |
|
|
2020
Q1 | $90K | Buy |
12,436
+191
| +2% | +$1.38K | ﹤0.01% | 3113 |
|
|
2019
Q4 | $128K | Sell |
12,245
-1,501
| -11% | -$15.7K | ﹤0.01% | 3083 |
|
|
2019
Q3 | $851K | Buy |
13,746
+640
| +5% | +$39.6K | ﹤0.01% | 2617 |
|
|
2019
Q2 | $936K | Buy |
13,106
+3,662
| +39% | +$262K | ﹤0.01% | 2593 |
|
|
2019
Q1 | $451K | Buy |
9,444
+4,128
| +78% | +$197K | ﹤0.01% | 2793 |
|
|
2018
Q4 | $321K | Sell |
5,316
-87
| -2% | -$5.25K | ﹤0.01% | 2910 |
|
|
2018
Q3 | $573K | Buy |
5,403
+1,236
| +30% | +$131K | ﹤0.01% | 2786 |
|
|
2018
Q2 | $267K | Buy |
4,167
+148
| +4% | +$9.48K | ﹤0.01% | 3008 |
|
|
2018
Q1 | $270K | Buy |
+4,019
| New | +$270K | ﹤0.01% | 2908 |
|